2023. Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study). Clinics. 78, (Jun. 2023), 100240. DOI:https://doi.org/10.1016/j.clinsp.2023.100240.